Autoplaque vs uCT 780

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Autoplaque

by APQ Health (formerly Cedars-Sinai Medical Center: AIM)

uCT 780

by United Imaging Healthcare

AI Verdict

Tool B (uCT 780) is a CT imaging device that acquires high-quality cardiac and anatomical scans, leveraging AI for optimized workflows and low-dose imaging. Tool A (Autoplaque) is a software application designed to perform AI-powered quantitative analysis of coronary plaques and stenoses from CT angiography images, aiding in risk prediction. While both are relevant to cardiac imaging and utilize AI, they serve distinct functions in the diagnostic process: one for image acquisition and the other for post-acquisition image analysis.

Choose Autoplaque if…

Choose Autoplaque if your facility already acquires CT angiography images and you need an AI-powered software solution to precisely quantify coronary plaque burden and luminal stenoses for advanced heart attack risk stratification. This tool is ideal for clinicians seeking automated, detailed analysis of existing scans to guide treatment decisions and monitor disease progression.

View Autoplaque →

Choose uCT 780 if…

Choose the uCT 780 if your primary need is to acquire high-quality, low-dose CT images, especially for complex cardiac and detailed anatomical studies. This 160-slice CT scanner is best suited for institutions looking to upgrade their imaging hardware with advanced AI-powered workflows and technologies for superior image acquisition and patient safety.

View uCT 780 →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Autoplaque	uCT 780
Deployment	Workstation-based post-processing application, runs on Windows or Mac OS.	On-premise
FDA Status	Cleared AI-estimated	Cleared AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Autoplaque

Autoplaque explicitly highlights features that enhance clinician interaction with the analytical results, such as reviewable and editable segmentations, indicating a focus on the end-user's experience with the diagnostic output. In contrast, the uCT 780's AI-powered workflow primarily benefits the imaging acquisition process for technicians, not necessarily the clinician's direct interaction with the analyzed data.

Clinical Value

Autoplaque

While both offer significant clinical value, Autoplaque directly provides AI-powered quantitative analysis for heart attack risk prediction and treatment guidance, offering immediate diagnostic and prognostic insights to clinicians. The uCT 780, while crucial for generating high-quality images, is an imaging device whose AI primarily enhances image acquisition rather than direct clinical interpretation.

Pricing & Value

Tie

Neither tool discloses its pricing, which is common for specialized medical software and large medical devices. Without any pricing information or details on total cost of ownership, it is impossible to compare their relative value.

Enterprise Readiness

uCT 780

The uCT 780 explicitly states both HIPAA compliance and the availability of a Business Associate Agreement (BAA), which are critical requirements for enterprise deployment in healthcare. Autoplaque does not specify these crucial compliance details, making Tool B demonstrably more ready for enterprise integration from a regulatory and contractual standpoint.

Innovation

uCT 780

The uCT 780 showcases a broader range of innovations, integrating AI into the imaging workflow alongside advanced hardware technologies for superior image quality, speed, and reduced radiation dose. While Autoplaque's AI analysis is innovative, the uCT 780 presents a more comprehensive and multi-faceted approach to innovation across the entire imaging process.

Support & Docs

Tie

Neither the provided structured facts nor a general web search yielded specific information regarding the availability or quality of support and documentation for either tool. Therefore, it is not possible to distinguish between them on this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Autoplaque	uCT 780
Product Type	AI-powered software for quantitative analysis	160-slice CT scanner
Company	Cedars-Sinai Medical Center: AIM	Shanghai United Imaging Healthcare Co.
Primary Application	Quantitative analysis of coronary plaques and luminal stenoses from CT angiography images	High-quality, low-dose imaging, particularly for cardiac and detailed anatomical scans
Specialties Supported	Cardiology, Radiology	Cardiology, Interventional Radiology, Radiology
Core Technology/Function	AI-powered quantitative analysis of atherosclerotic plaque, detection, characterization, and measurement of stenoses	160-slice CT scanner with uAI Vision 3D camera for AI-empowered workflow and advanced hardware for imaging

Videos

Demos, reviews, and walkthroughs featuring Autoplaque and uCT 780.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What is the fundamental difference in function between Autoplaque and uCT 780?

Autoplaque is an AI-powered software designed for quantitative analysis of coronary plaques and luminal stenoses from existing CT angiography images, aiding in heart attack risk prediction. In contrast, the uCT 780 is a 160-slice CT scanner that acquires high-quality, low-dose medical images, particularly for cardiac and detailed anatomical scans, integrating AI into its imaging workflows.

How do the AI capabilities differ between Autoplaque and uCT 780?

Autoplaque's AI is focused on quantitative analysis, detection, and characterization of coronary artery plaque and measurement of luminal stenoses from CT angiography images. The uCT 780 integrates AI-powered workflows, such as the uAI Vision 3D camera, to enhance the imaging acquisition process, improve image quality, and enable low-dose imaging.

What are the data privacy and compliance considerations for each tool?

The uCT 780 explicitly states that it is HIPAA compliant and has a Business Associate Agreement (BAA) available. The provided information for Autoplaque does not specify its HIPAA compliance or BAA availability.

What specific clinical problems do these tools address in cardiology?

Autoplaque aids in heart attack risk prediction and treatment guidance by providing quantitative analysis of atherosclerotic plaque and luminal stenoses. The uCT 780 offers advanced cardiac diagnostics through high-quality, low-dose imaging, including features like CardioXphase technology, which is crucial for detailed anatomical scans of the heart.